Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Record total revenues of $211.6 million and $719.0 million in the fourth quarter and full year 2025, a 21% and 9% increase compared to same ...

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the last patient has ...

Beyond sexual health risks, chemsex is linked to serious mental health consequences influenced by how often, how intensely and how substances are used.

Late-Stage Pipeline Advancements and Novel Therapies Position Sector for Accelerated Growth and Major Value CatalystsMarket News Updates News ...

Around 9.4million people in the UK are now thought to be living with anxiety or another mental health condition, an NHS campaign has revealed.

A recent review of animal research suggests that caffeine might help ease symptoms of anxiety and depression by reducing inflammation in the brain. The researchers analyzed multiple experiments and ...

Some experts recommend smoking rather than injecting fentanyl to avoid needle-related diseases. But, smoking fentanyl is dangerous and can lead to second and third-hand exposures.

By bringing gravity into the equation, we can focus on effective strategies for managing IBS in space and on Earth.

Shares of at least four other developers were up by mid-single digits to low-double digits at certain points on Tuesday.

Biotech hot picks spotlight Xenon, United Therapeutics and Axsome as Phase III data and FDA decisions approach.